ASTEC — Astec Lifesciences Income Statement
0.000.00%
Last trade - 00:00
- IN₹21.97bn
- IN₹26.24bn
- IN₹6.28bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,309 | 5,226 | 5,549 | 6,766 | 6,282 |
Cost of Revenue | |||||
Gross Profit | 1,237 | 1,476 | 1,781 | 2,369 | 1,695 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,737 | 4,604 | 4,690 | 5,569 | 5,850 |
Operating Profit | 572 | 622 | 859 | 1,197 | 431 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 559 | 614 | 891 | 1,211 | 349 |
Provision for Income Taxes | |||||
Net Income After Taxes | 358 | 475 | 651 | 899 | 256 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 357 | 475 | 650 | 899 | 256 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 357 | 475 | 650 | 899 | 256 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 18.3 | 24.3 | 33.2 | 45.8 | 13.2 |
Dividends per Share |